Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response

By Soboll G.   Nelson K.M.   Leuthner E.S.   Clark R.J.   Drape R.   Macklin M.D.   Swain W.F.   Olsen C.W.   Lunn D.P.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 3081-3092

Elsevier

Access to resources Recommend Favorite

Oral administration of a bacterial immunomodulator enhances the immune response to cholera toxin

By Flo J.   Goldman H.   Roux M.E.   Massouh E.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1167-1173

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver

By Rogers J.V.   Hull B.E.   Fink P.S.   Chiou H.C.   Bigley N.J.  

Vaccine, Vol. 18, Iss. 15, 2000-02 ,pp. : 1522-1530

Elsevier

Access to resources Recommend Favorite

Humoral and cellular immune responses to HIV-1 Nef in mice DNA-immunised with non-replicating or self-replicating expression vectors

By Collings A.   Pitkanen J.   Strengell M.   Tahtinen M.   Pitkanen J.   Lagerstedt A.   Hakkarainen K.   Ovod V.   Sutter G.   Ustav M.   Ustav E.   Mannik A.   Ranki A.   Peterson P.   Krohn K.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 460-467

Elsevier

Access to resources Recommend Favorite